R&D Systems™ Recombinant Human CXCL1/GRO alpha (aa 39-107) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human CXCL1/GRO alpha (aa 39-107) Protein is derived from E. coli. The Recombinant Human CXCL1/GRO alpha (aa 39-107) Protein has been validated for the following applications: Bioactivity.

Order Info

The product is shipped at ambient temperature.

The product is shipped at ambient temperature.

Specifications

• Accession Number: Q5M8T4
• For Use With (Application): Bioactivity
• Formulation: Without BSA as carrier
• Gene ID (Entrez): 1490
• Molecular Weight (g/mol): 6 kDa, reducing conditions
• Quantity: 25 μg
• Source: E. coli-derived human CXCL1/GRO alpha/KC/CINC-1 protein Thr39-Asn107
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1μg of protein by LAL method
• Gene Alias: CINC1, CINC-1, FSP, GRO alpha, GRO1, GROa, KC, MGSA, MGSA-a, MGSA-alpha, NAP-3, SCYB1
• Biological Activity: 0.15 to 0.9ng/mL (ED 50)
• Product Type: Recombinant protein
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Protein Tag: No
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

For Research Use Only